4.3 Review

Bioinformatics tools for secretome analysis

期刊

出版社

ELSEVIER
DOI: 10.1016/j.bbapap.2013.01.039

关键词

Secretome data analysis; System biology; Bioinformatics; Biological database; Proteomics

资金

  1. Associazione Italiana per la Ricerca sul Cancro (AIRC) [5896, 12162]
  2. Italian Istituto Superiore di Sanita

向作者/读者索取更多资源

Over recent years, analyses of secretomes (complete sets of secreted proteins) have been reported in various organisms, cell types, and pathologies and such studies are quickly gaining popularity. Fungi secrete enzymes can break down potential food sources; plant secreted proteins are primarily parts of the cell wall proteome; and human secreted proteins are involved in cellular immunity and communication, and provide useful information for the discovery of novel biomarkers, such as for cancer diagnosis. Continuous development of methodologies supports the wide identification and quantification of secreted proteins in a given cellular state. The role of secreted factors is also investigated in the context of the regulation of major signaling events, and connectivity maps are built to describe the differential expression and dynamic changes of secretomes. Bioinformatics has become the bridge between secretome data and computational tasks for managing, mining, and retrieving information. Predictions can be made based on this information, contributing to the elucidation of a given organism's physiological state and the determination of the specific malfunction in disease states. Here we provide an overview of the available bioinformatics databases and software that are used to analyze the biological meaning of secretome data, including descriptions of the main functions and limitations of these tools. The important challenges of data analysis are mainly related to the integration of biological information from dissimilar sources. Improvements in databases and developments in software will likely substantially contribute to the usefulness and reliability of secretome studies. This article is part of a Special Issue entitled: An Updated Secretome. (C) 2013 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial

Tiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, Tadeusz Pienkowski, Young-Hyuck Im, Giulia Valeria Bianchi, Barbara Galbardi, Matteo Dugo, Loris De Cecco, Ling-Ming Tseng, Mei-Ching Liu, Begona Bermejo, Vladimir Semiglazov, Giulia Viale, Juan de la Haba-Rodriguez, Do-Youn Oh, Brigitte Poirier, Pinuccia Valagussa, Luca Gianni, Elda Tagliabue

Summary: In HER2-positive/ER-positive breast cancer, the 41-gene classifier TRAR has been identified as an independent predictor of pCR, serving as a promising tool to select patients responsive to anti-HER2-based neoadjuvant therapy and to assist in treatment escalation and de-escalation strategies.

MOLECULAR ONCOLOGY (2022)

Article Multidisciplinary Sciences

Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer

Marco Silvestri, Matteo Dugo, Marta Vismara, Loris De Cecco, Davide Lanzoni, Andrea Vingiani, Secondo Folli, Maria Carmen De Santis, Filippo de Braud, Giancarlo Pruneri, Serena Di Cosimo, Vera Cappelletti

Summary: This study analyzed the copy number alterations (CNAs) of triple negative breast cancer (TNBC) patients before and after neoadjuvant chemotherapy (NAC) using next-generation sequencing. The study revealed common CNAs on chromosomes 1, 2, and 8 in pre-treatment tumor samples, and identified MSH2, PRDM1, and PAX3 as genes associated with pathological complete response. CNAs detected after treatment involved genes within druggable pathways. Furthermore, the analysis of circulating tumor cells (CTCs) showed the impact of NAC on tumor evolution and driver event selection.

SCIENTIFIC REPORTS (2022)

Article Biotechnology & Applied Microbiology

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma

Rihan El Bezawy, Stefano Percio, Chiara Maura Ciniselli, Michelandrea De Cesare, Gennaro Colella, Matteo Dugo, Silvia Veneroni, Valentina Doldi, Silvia Martini, Dario Baratti, Shigeki Kusamura, Paolo Verderio, Marcello Deraco, Paolo Gandellini, Nadia Zaffaroni, Valentina Zuco

Summary: In this study, miR-550a-3p was found to be downregulated in DMPM patients and its expression levels were associated with patient outcome. Functional experiments showed that miR-550a-3p inhibited proliferation and invasiveness, enhanced apoptosis, and reduced tumor growth in DMPM cell lines and xenograft models. Similar antitumor effects were observed in prostate and ovarian cancer cell lines. The effects of miR-550a-3p were mediated, at least in part, by the inhibition of HSP90AA1 and its target proteins.

CANCER GENE THERAPY (2022)

Meeting Abstract Oncology

Comparison of early modulation of biological pathways and immune microenvironment by anthracyclines- or taxane-based treatment

Maurizio Callari, Marco Barreca, Matteo Dugo, Barbara Galbardi, Lucia Vigano, Alberta Locatelli, Luca Licata, Giulia Viale, Pinuccia Valagussa, Giuseppe Viale, Luca Gianni, Giampaolo Bianchini

CANCER RESEARCH (2022)

Meeting Abstract Oncology

Predictive value of RT-qPCR 27-gene IO score and comparison with RNA-Seq IO score in the NeoTRIPaPDL1 trial

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle, Begona Bermejo, Claudio Zamagni, Robert S. Seitz, Tyler J. Nielsen, Marc Thill, Antonio Anton, Stefania Russo, Eva Maria Ciruelos, Brock L. Schweitzer, Douglas T. Ross, Barbara Galbardi, Richard Greil, Vladimir Semiglazov, Balazs Gyorffy, Marco Colleoni, Catherine Kelly, Gabriella Mariani, Lucia Del Mastro, Pinuccia Valagussa, Giuseppe Viale, Maurizio Callari, Luca Gianni, Giampaolo Bianchini

CANCER RESEARCH (2022)

Meeting Abstract Oncology

Triple negative breast cancer subtypes and early dynamics of the 27-gene IO score predict pCR in the NeoTRIPaPDL1 trial

Matteo Dugo, Chiun-Sheng Huang, Daniel Egle, Begona Bermejo, Claudio Zamagni, Robert S. Seitz, Tyler J. Nielsen, Marc Thill, Antonio Anton, Stefania Russo, Eva Maria Ciruelos, Brock L. Schweitzer, Douglas T. Ross, Barbara Galbardi, Richard Greil, Vladimir Semiglazov, Balazs Gyorffy, Marco Colleoni, Catherine Kelly, Gabriella Mariani, Lucia Del Mastro, Pinuccia Valagussa, Giuseppe Viale, Maurizio Callari, Luca Gianni, Giampaolo Bianchini

CANCER RESEARCH (2022)

Meeting Abstract Oncology

Immune milieu associated with PD-L1 status in TNBC is dependent on time of biomarker assessment and treatment received: A secondary analysis of the NeoTRIPaPDL1 trial

Maurizio Callari, Chiun-Sheng Huang, Daniel Egle, Begona Bermejo, Claudio Zamagni, Matteo Dugo, Marc Thill, Antonio Anton, Marco Barreca, Stefania Russo, Eva Maria Ciruelos, Richard Greil, Stefania Zambelli, Balazs Gyorffy, Chanel Smart, Olivia Biasi, Pinuccia Valagussa, Giuseppe Viale, Luca Gianni, Giampaolo Bianchini

CANCER RESEARCH (2022)

Article Oncology

Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast Cancer

Lucia Vigano, Alberta Locatelli, Adele Ulisse, Barbara Galbardi, Matteo Dugo, Diego Tosi, Carlo Tacchetti, Tiziana Daniele, Balazs Gyorffy, Lorenzo Sica, Marina Macchini, Milvia Zambetti, Stefania Zambelli, Giampaolo Bianchini, Luca Gianni

Summary: This study investigates the interplay between ER and HER2 and its impact on the growth and progression of ER-positive breast cancer. It finds that combination therapy can bypass resistance mechanisms and that RTK functional activation may be an alternative survival pathway in ER+/HER2(low) tumors.

CLINICAL CANCER RESEARCH (2022)

Article Oncology

Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients

Emanuela Fina, Loredana Cleris, Matteo Dugo, Mara Lecchi, Chiara Maura Ciniselli, Daniele Lecis, Giulia Valeria Bianchi, Paolo Verderio, Maria Grazia Daidone, Vera Cappelletti

Summary: The study highlights the importance of understanding the hematogenous phase of breast cancer metastasis and identifies genes associated with metastasis through transcriptome analysis of circulating tumor cells. These findings provide valuable information on disease progression and potential therapeutic targets.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Dermatology

Genetic Layout of Melanoma Lesions Is Associated with BRAF/MEK-Targeted Therapy Resistance and Transcriptional Profiles

Elisabetta Vergani, Adele Busico, Matteo Dugo, Andrea Devecchi, Barbara Valeri, Mara Cossa, Lorenza Di Guardo, Loris De Cecco, Erika Feltrin, Giorgio Valle, Paola Deho, Simona Frigerio, Luca Lalli, Gianfrancesco Gallino, Michele Del Vecchio, Mario Santinami, Giancarlo Pruneri, Elena Tamborini, Licia Rivoltini, Marialuisa Sensi, Viviana Vallacchi, Monica Rodolfo

Summary: The genetic landscape of melanoma resistance to targeted therapy with small molecules inhibiting BRAF and MEK kinases was explored in this study. Somatic alterations in resistant melanoma were characterized and their integration with transcriptional profiles revealed enrichment in gene families involved in oncogenic signaling pathways and DNA repair. The analysis also showed positive modulation of gene signatures associated with anabolic processes, chromatin alterations, and IFN-a response. MTORC1 signaling was found to be enriched in poorly responsive patients and resistant tumors. These findings provide insights into the genetic patterns underlying melanoma resistance and have implications for personalized therapies.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Oncology

Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples

Emanuela Minna, Paola Romeo, Matteo Dugo, Loris De Cecco, Antonella Aiello, Federico Pistore, Andrea Carenzo, Angela Greco, Maria Grazia Borrello

Summary: Medullary thyroid carcinoma (MTC) is a rare but aggressive tumor. The mechanisms underlying MTC development and associated signaling pathways are not fully understood. In this study, we analyzed mutation and gene expression profiles of 17 MTCs, including primary and metastatic tumors, and identified uncommon gene alterations. We also identified distinct signaling subtypes based on gene expression signatures. Our findings suggest that there are emerging gene drivers in MTC and highlight the importance of understanding the molecular subtypes of MTC.

CANCERS (2022)

Article Oncology

Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer

Lorenzo Castagnoli, Simona Corso, Alma Franceschini, Alessandra Raimondi, Sara Erika Bellomo, Matteo Dugo, Federica Morano, Michele Prisciandaro, Silvia Brich, Antonino Belfiore, Andrea Vingiani, Maria Di Bartolomeo, Giancarlo Pruneri, Elda Tagliabue, Silvia Giordano, Filippo Pietrantonio, Serenella M. Pupa

Summary: In this study, cotargeting HER2 and FASN was found to enhance the efficacy of anti-HER2 therapy, providing a new opportunity for treating trastuzumab-resistant HER2+ gastric cancer.

CELLULAR ONCOLOGY (2023)

Article Multidisciplinary Sciences

Noninvasive morpho-molecular imaging reveals early therapy-induced senescence in human cancer cells

Arianna Bresci, Jeong Hee Kim, Silvia Ghislanzoni, Francesco Manetti, Lintong Wu, Federico Vernuccio, Chiara Ceconello, Salvatore Sorrentino, Ishan Barman, Italia Bongarzone, Giulio Cerullo, Renzo Vanna, Dario Polli

Summary: Screening for anticancer therapy in vitro can lead to the identification of additional treatments and improve clinical outcomes. This study demonstrates the potential of all-optical, label-free, and quantitative microscopy techniques in early detection of therapy-induced senescent cells in tumor cells, providing a rapid and accurate method for research in anticancer treatment.

SCIENCE ADVANCES (2023)

Article Chemistry, Analytical

Optical Diffraction Tomography and Raman Confocal Microscopy for the Investigation of Vacuoles Associated with Cancer Senescent Engulfing Cells

Silvia Ghislanzoni, Jeon Woong Kang, Arianna Bresci, Andrea Masella, Koseki J. Kobayashi-Kirschvink, Dario Polli, Italia Bongarzone, Peter T. C. So

Summary: This study used optical diffraction tomography and Raman spectroscopy to analyze the structure of vacuoles in cancer cells and detect chemical species within them. The researchers found that the vacuoles contained diluted cell-derived macromolecules and could be distinguished from the surrounding medium and cells using their Raman fingerprint. This noninvasive approach is valuable for studying complex biological processes.

BIOSENSORS-BASEL (2023)

Article Oncology

Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy

Luca Licata, Marco Barreca, Barbara Galbardi, Matteo Dugo, Giulia Viale, Balazs Gyorffy, Thomas Karn, Lajos Pusztai, Luca Gianni, Maurizio Callari, Giampaolo Bianchini

Summary: Luminal breast cancers with high proliferation and low ER signaling have poor prognosis. These tumors show high response to chemotherapy, but resistance to endocrine therapy and palbociclib. Immunotherapy may play a potential role in treating these tumors.

BRITISH JOURNAL OF CANCER (2023)

Article Biochemistry & Molecular Biology

Structural conservation in the glutathione binding in Sphingomonas sp. glutaredoxin Grx3 and variations for cold adaptation

Trang Van Tran, Hoa Nguyen, Luyen Vu, ChangWoo Lee

Summary: Glutaredoxin 3 (Grx3) is a redox protein that maintains structural integrity and glutathione (GSH) binding capabilities across different temperatures. This study investigates the roles of specific bonds in Grx3's structure and function, and how psychrophilic Grx3 variants adapt to cold environments. The highly conserved Arg51-Asp69 salt bridge and Gln56-His63 hydrogen bond are crucial for stabilizing the structure and catalytic activity of Grx3. Psychrophilic variants of Grx3 have adapted to cold environments by reducing GSH binding and increasing structural flexibility.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2024)

Article Biochemistry & Molecular Biology

Structural characterization of the human DjC20/HscB cochaperone in solution

Amanda Lais de Souza Coto, Arthur Alexandre Pereira, Sabrina Dorta Oliveira, Milene Nobrega de Oliveira Moritz, Arthur Moraes Franco da Rocha, Paulo Roberto Dores-Silva, Noeli Soares Melo da Silva, Ana Rita de Araujo Nogueira, Lisandra Marques Gava, Thiago Vagas Seraphim, Julio Cesar Borges

Summary: J-domain proteins form a large molecular chaperone family involved in proteostasis processes, with hDjC20 playing a vital role in mitochondria and being heavily influenced by the presence of Zn+2.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2024)

Article Biochemistry & Molecular Biology

The regulation of RGLG2-VWA by Ca2+ions

Meiling Zhang, Jiaxiang Zhang, Yan Liang, Shicheng Tian, Shuyang Xie, Tong Zhou, Qin Wang

Summary: This study determined the crystal structures of RGLG2 VWA domain in Arabidopsis thaliana, revealing that Ca2+ ions act as regulators and affect the conformational change of RGLG2-VWA domain.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2024)

Article Biochemistry & Molecular Biology

Calcium binding of AtCBL1: Structural and functional insights

Alexandra Bork, Sander H. J. Smits, Lutz Schmitt

Summary: This study reveals the structure and calcium ion binding properties of CBL1 protein, and proposes a binding model of CBL1 for Ca2+. Additionally, it provides preliminary insights into the formation of the dimer interface of CBL1.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2024)

Article Biochemistry & Molecular Biology

Bacteriophage-encoded chaperonins stimulate prion protein fibrillation in an ATP-dependent manner

Evgeniia V. Leisi, Andrey V. Moiseenko, Sofia S. Kudryavtseva, Denis V. Pozdyshev, Vladimir I. Muronetz, Lidia P. Kurochkina

Summary: The pathogenesis of prion diseases involves the transformation of prion protein into an insoluble form. This study found that two phage chaperonins can promote the fibrillation of prion protein in an ATP-dependent manner, resulting in the formation of less toxic large clusters. These fibrils differ in morphology and properties from those formed spontaneously in acidic pH with denaturants.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2024)

Article Biochemistry & Molecular Biology

Importance of aspartate 4 in the Mg2+dependent regulation of Leishmania major PAS domain-containing phosphoglycerate kinase

Gaurab Chowdhury, Saroj Biswas, Yuthika Dholey, Puja Panja, Sumit Das, Subrata Adak

Summary: Magnesium is an important divalent cation for regulating enzyme activity. The binding of Mg2+ through the PAS domain inhibits phosphoglycerate kinase (PGK) activity in LmPAS-PGK at neutral pH, but PGK activity is derepressed at acidic pH. Mutation studies revealed that the Asp-4 residue is crucial for Mg2+ binding at neutral pH.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2024)

Article Biochemistry & Molecular Biology

Rational design engineering of a more thermostable Sulfurihydrogenibium yellowstonense carbonic anhydrase for potential application in carbon dioxide capture technologies

Shima Ghaedizadeh, Majid Zeinali, Bahareh Dabirmanesh, Behnam Rasekh, Khosrow Khajeh, Ali Mohammad Banaei-Moghaddam

Summary: Implementing hyperthermostable carbonic anhydrases into CO2 capture and storage technologies can increase the rate of CO2 absorption from industrial flue gases. This study successfully improved the thermostability of a known hyperthermostable carbonic anhydrase through rational engineering of a single-point mutation.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2024)

Article Biochemistry & Molecular Biology

Structural and functional characterisation of Tst2, a novel TRPV1 inhibitory peptide from the Australian sea anemone Telmatactis stephensoni

Khaled A. Elnahriry, Dorothy C. C. Wai, Lauren M. Ashwood, Muhammad Umair Naseem, Tibor G. Szanto, Shaodong Guo, Gyorgy Panyi, Peter J. Prentis, Raymond S. Norton

Summary: Sea anemone venom contains a peptide called Tst2, which shows sequence similarity to peptides that interact with various ion channels. Recombinant Tst2 was successfully produced and its structure and function were studied. The results showed that Tst2 is an inhibitor of the TRPV1 channel.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2024)